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Aims Cardiac malformations are prevalent in trisomies of human chromosome 21 [Down’s syndrome (DS)], affecting
normal chamber separation in the developing heart. Efforts to understand the aetiology of these defects have
been severely hampered by the absence of an accurate mouse model. Such models have proved challenging to estab-
lish because synteny with human chromosome Hsa21 is distributed across three mouse chromosomes. None of
those engineered so far accurately models the full range of DS cardiac phenotypes, in particular the profound dis-
ruptions resulting from atrioventricular septal defects (AVSDs). Here, we present analysis of the cardiac malfor-
mations exhibited by embryos of the transchromosomic mouse line Tc(Hsa21)1TybEmcf (Tc1) which contains
more than 90% of chromosome Hsa21 in addition to the normal diploid mouse genome.
Methods and
results
Using high-resolution episcopic microscopy and three-dimensional (3D) modelling, we show that Tc1 embryos
exhibit many of the cardiac defects found in DS, including balanced AVSD with single and separate valvar orifices,
membranous and muscular ventricular septal defects along with outflow tract and valve leaflet abnormalities. Fre-
quencies of cardiac malformations (ranging from 38 to 55%) are dependent on strain background. In contrast, no
comparable cardiac defects were detected in embryos of the more limited mouse trisomy model, Dp(16Cbr1-
ORF9)1Rhr (Ts1Rhr), indicating that trisomy of the region syntenic to the Down’s syndrome critical region, including
the candidate genes DSCAM and DYRK1A, is insufficient to yield DS cardiac abnormalities.
Conclusion The Tc1 mouse line provides a suitable model for studying the underlying genetic causes of the DS AVSD cardiac
phenotype.
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1. Introduction
Down’s syndrome (DS) results from trisomy of human chromosome
21 (Hsa21) and in the absence of first trimester screening and occurs
in 1 in 800 live births.1 A complex disorder, DS, is characterized by
many phenotypic features and 40–60% of individuals with DS have
some congenital heart defect (CHD). These range from defects in
chamber separation to more complex abnormalities affecting multiple
aspects of cardiac anatomy (e.g. tetralogy of Fallot). The most
common abnormalities affect the atrioventricular (AV) junction,2 indi-
cating an effect of trisomy on early heart morphogenesis.
Understanding the aetiology of DS phenotypes has proved challenging
not only because of the large number of trisomic genes, but also because
the majority of DS phenotypes (including those affecting the heart) are
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partially penetrant, varying in severity between individuals. Rare cases of
segmental trisomy 21 have been used in efforts to define a ‘critical region’
responsible for major DS phenotypes3,4 and to correlate trisomy of
specific genes/regions with specific aspects of DS.5
Mouse models of DS offer an alternative approach, holding the
promise of experimental intervention to test phenotype–genotype
interactions. However, since the mouse orthologues to genes on
Hsa21 are found on three different mouse chromosomes, Mus muscu-
lus (Mmu) 16, 17, and 10, generating mouse models of DS has proved
complex.6 To overcome the difficulties inherent in this dispersal of
synteny, a transchromosomic mouse containing Hsa21 has been gen-
erated.7 The Tc(Hsa21)1TybEmcf (Tc1) mouse contains a freely seg-
regating, and near complete, copy of Hsa21 which is retained
mosaically throughout the tissues of the mouse and exhibits a
broad range of DS-like phenotypes, including craniofacial abnormal-
ities, motor coordination deficits, and cognitive impairment.
A striking feature of the cardiac abnormalities associated with DS is
the prevalence of malformations affecting the entire AV junction. In the
DS AV septal defect (AVSD), the primary malformation is the retention
of a common AV junction, balanced in its connection to the right and
left ventricles. This disrupts the normal arrangement of leaflets that
form the mitral and tricuspid valves and is generally associated with
septal defects that result in shunting at the atrial or ventricular level.8
None of the mouse models based on complete or partial trisomies
of Mmu16 described so far have been reported to recapitulate this
most complex and common DS cardiac malformation.9,10
One difficulty in identifying and characterizing such defects is the
complex and rapidly changing morphology of the mammalian heart
during the period in which the looped heart tube is transformed
into a chambered organ. Visualizing initial defects in AV cushion for-
mation and fusion requires histological levels of resolution, but
using a two-dimensional method to examine a complex, three-
dimensional (3D) transformation has its own inherent limitations.
Equally challenging, the variable penetrance of trisomy phenotypes
requires analysis of significant embryo numbers. To overcome both
problems, we have utilized high-resolution episcopic microscopy
(HREM) as a rapid way to obtain highly detailed 3D models of
mouse embryo hearts, while retaining the ability to examine individual
tissue sections by histology.11 We have used this approach to analyse
the frequency and type of cardiac malformations detected in trans-
chromosomic Tc1 embryos.
2. Methods
2.1 Mouse lines
All animal work conformed to the Guide for the Care and Use of Labora-
tory Animals published by the US National Institutes of Health (NIH Pub-
lication No. 85-23, revised 1996) and was approved by the NIMR Ethical
Review Panel.
Transchromosomic Tc(Hsa21)1TybEmcf (Tc1) mouse embryos and
their wild-type littermates were obtained by crossing 129S8:C57BL/6J
(F1) Tc1 females with 129S8:C57BL/6J (F1) males or C57BL/6J males
and genotyping by polymerase chain reaction (PCR).7
Ts1Rhr mice12 are trisomic only for the region of Mmu16 syntenic with
the 33 gene-containing region of Hsa21 termed the Down’s syndrome
critical region (DSCR).3,4 Ts1Rhr embryos and their wild-type littermates
were obtained for analysis from crosses of C57BL/6J females and
129S8:C57BL/6J (F1) Ts1Rhr males (genotypes determined by PCR; see
Supplementary material online).
2.2 HREM imaging, 3D modelling,
and histology
Embryonic hearts were dissected from surrounding tissue and fixed for
30 min in 4% paraformaldehyde followed by a 1 h wash in distilled
water and secondary fixation overnight. Samples were dehydrated and
embedded in modified JB4 methacrylate resin.11 E14.5 and E18.5 hearts
were sectioned at 2 and 3 mm, respectively. Selected sections were
stained with haematoxylin and eosin, as described by the manufacturer
(Sigma-Aldrich). HREM imaging (isometric resolutions of 2 or 3 mm)
used a Jenoptik C14 plus CCD camera (1360 × 1024 pixels). Data sets
were normalized and subsampled prior to 3D volume rendering using
OsiriX 3.13
2.3 Classification of VSDs
In humans, VSDs have historically been classified in a number of different
ways based variously on the position of the septal lesion (as viewed from
the right ventricle) or on the anatomic nature of the lesion borders.
Classification of the VSD subtype using a combination of both approaches
(led by the border classification) has been advocated to give a clear cat-
egorization that is particularly useful in a clinical setting when preparing
for surgical repair.14,15 We have used this approach to analyse the
septal defects in mouse embryos, dividing the right view of the ventricular
septum into membranous (M), outlet (O), inlet (I), and trabeculated (T)
regions and distinguishing three subtypes of VSD by the nature of their
borders: (i) perimembranous VSD, in which part of the border of the
hole is formed by fibrous continuity between leaflets of an arterial valve
and an AV valve; (ii) muscular VSD in which the holes in the ventricular
septum have exclusively muscular borders; and (iii) lesions in which part
of the border is formed by fibrous continuity between the leaflets of
the arterial valves.
2.4 Classification of AVDSs
In humans, AVSD covers a spectrum of disorders, all of which have the essen-
tial morphological hallmark of a common AV junction guarded by a five-
leaflet valve, with two ‘bridging’ leaflets lying across the ventricular
septum.8 The bridging leaflets can be anchored to the atrial septum, more
commonly the ventricular septum (ostium primum defect) or neither.
They may also be joined by a tongue of valvar tissue, resulting in separate
left and right orifices that remain within a common AV junction. Finally,
the common AV junction may be shared equally between left and right ven-
tricles (or ‘balanced’), or the ventricular septum can be shifted to give a spec-
trum of left or right ventricular dominance (hence termed ‘unbalanced’).
3. Results
3.1 E14.5 Tc1 embryos exhibit a high
incidence of heart defects
Establishing an accurate mouse model of the cardiac defects associ-
ated with DS would be an important step towards identifying their
underlying molecular lesions. In the initial report describing the Tc1
mouse,7 abnormalities in the embryonic heart were observed but
their character was largely unexplored. Although a single E14.5
embryo showed failure in fusion of superior and inferior AV cushions
indicative of an AV junction defect, neither the structure of this
abnormality nor its similarity to DS AVSD was assessed. By using high-
resolution episcopic microscopy, we have now been able to under-
take a comprehensive analysis of Tc1 heart morphology, using 3D
volume rendering and digital resectioning to compare the full spec-
trum of defects with those found in DS.
Embryos generated with C57BL/6J males had a higher phenotype
incidence (55%, n ¼ 49) than those generated with 129S8:C57BL/6J
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(F1) males (38%, n ¼ 29), suggesting a higher susceptibility to heart
defects in mice with C57BL/6J rich backgrounds. Heart phenotypes
affected ventricular septation, outflow tract position, and AV canal
development (Table 1), either alone or in combination with no
other differences (such as chamber size or wall thickness) distinguish-
ing trisomic embryos from their control littermates.
3.2 Septal defects and abnormal arterial
trunk arrangements in Tc1 embryos
Forty-seven per cent of Tc1 samples (37 of 78 embryos) exhibited
VSD (Table 1). Adopting the classification system15 advocated for
clinical use (see Section 2), only two subtypes of VSD were observed
in Tc1 embryonic hearts at E14.5: perimembranous VSD (Figure 1D
and F; see Supplementary material online, Movie S1) positioned in
the membranous region of the ventricular septum and muscular
VSD (Figure 1G and I; see Supplementary material online, Movie S2)
which always opened into the inlet region of the ventricular septum
(Figure 1A–C ). The two subtypes of VSD were observed alone,
together, or in association with other heart malformations (see Sup-
plementary material online, Table S1).
Defects in the outflow tract were also observed in 22% of Tc1
samples (17 of 78 embryos, Table 1). All of these defects were
observed in association with VSD and the majority affected position-
ing of the aorta (Figure 2; see Supplementary material online, Movies S3
and S4). Several Tc1 samples showed an over-riding aorta, arising
from a central position directly above a VSD (Figure 2E and F ).
Other Tc1 hearts exhibited double-outlet right ventricle (DORV),
both pulmonary and aortic trunks arising from the right ventricle
(Figure 2G–I). In all but one of the wild-type embryos from Tc1
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Table 1 Cardiovascular defects are observed in Tc1 but not Ts1Rhr embryos
Stage Paternal background Heart defects Normal hearts % heart defects
Genotype VS AVC OFT
E14.5 129S8:C57BL/6J (F1) Wild-type (n ¼ 30) 3 0 0 27 10.0
Tc1 (n ¼ 29) 11 1 5 18 37.9§
E14.5 C57BL/6J Wild-type (n ¼ 51) 7 0 1 44 13.7
Tc1 (n ¼ 49) 26 15 12 22 55.1*
E18.5 C57BL/6J Wild-type (n ¼ 22) 0 0 0 22 0.0
Tc1 (n ¼ 33) 7 1 1 26 21.2#
E14.5 Wild-type (n ¼ 22) 0 0 0 22 0.0
Ts1Rhr (n ¼ 19) 1 0 0 18 5.3
A spectrum of heart malformations is observed in Tc1 hearts at E14.5 and E18.5, affecting the ventricular septum (VS), atrioventricular canal (AVC), and outflow tract (OFT). Ts1Rhr
hearts were no different to controls.
Significant difference to corresponding wild-type incidence (Fisher’s exact test): §P, 0.05, *P, 0.0001, and #P ¼ 0.034.
Figure 1 E14.5 Tc1 embryos exhibit ventricular septal defects. Three-dimensional reconstructions of wild-type (A, B, and E) and Tc1 (D, F, G, and
H ) hearts, eroded in the planes indicated in insets. (B and C) Division of the ventricular septum (right view) into membranous (M), outlet (O), inlet (I),
and trabeculated (T) regions. Many Tc1 samples have defects in the membranous region (white circle, D and inset). (E–G) Four-chambered view
showing membranous VSD (white arrow, F) and muscular inlet VSD (white arrow, G; the defect has an exclusively muscular border and opens to
the inlet region of the ventricular septum) in Tc1 hearts. (H) Short-axis view of a Tc1 muscular inlet VSD (white arrow, H ). (LA, left atrium; LV,
left ventricle; RA, right atrium; RV, right ventricle; M, membranous region; O, outlet region; I, inlet region; T, trabeculated region; A, aorta; PV, pul-
monary valve; PM, base of papillary muscle; TV, septal leaflet of tricuspid valve).
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litters, the septation and positioning of the outflow vessels was com-
pleted as expected by E14.5 (Figure 2A–C ). Inspection of the relative
positioning of arterial trunks, infundibular morphology, and relation-
ship of interventricular communication to the subarterial outflow
tracts revealed a variety of abnormal arrangements in samples
exhibiting DORV (Figure 3). One Tc1 embryo showed failure of sep-
tation of the two outflow vessels (common arterial trunk), resulting in
aortic-pulmonary continuity, with a doubly committed VSD (Figure 3A
and B). Subaortic ventricular communication was associated with
bilateral infundibulums and either side-by-side (Figure 3C and D) or
normal arrangement of arterial trunks (Figure 3E and F ). Subpulmon-
ary communication was also found in association with side-by-side
arterial trunks, equivalent to the Taussig–Bing anomaly in humans
(Figure 3G and H ).
3.3 AV canal defects in Tc1 embryos
We also identified malformations of the AV junction (4%, 3 of 78
embryos) and valve leaflets of the AV canal (17%, 13 of 78 embryos)
in E14.5 Tc1 embryos (21%, n ¼ 78; Table 1). In mouse, septation of
the AV junction separating the right and left sides of the AV canal
should be complete by E14.5 (Table 1) with the outflow tract of the
aorta occupying a ‘wedged’ position between the mitral valve and the
AV septum (Figure 4A and D). Three of the Tc1 embryos examined
showed disruption of these normal arrangements.
In Tc1 AVSD, we detected both balanced common (n ¼ 1, Figure 4B
and E; see Supplementary material online, Movie S5) and separate valvar
orifices (n ¼ 2; Figure 4C and F; see Supplementary material online,
Movie S6). In all cases, the bridging leaflets were anchored to the atrial
septum but not the ventricular septum, resulting in ventricular shunting
(e.g. Figure 4H). Tc1 AVSD also showed the classic ‘unwedged’ mor-
phology of the left outflow tract (n ¼ 2; Figure 4B and C) compared
with the ‘wedged’ position in a normal wild-type heart (Figure 4A and
D). Other Tc1 embryos showed normal AV junction morphology but
anomalies in valve leaflet morphology, showing either fat, enlarged leaf-
lets (n ¼ 7, Figure 4I), or a failure of fusion (cleft) in the aortic leaflet of
the mitral valve (n ¼ 6, Figure 4K and L). Together, these results
Figure 2 E14.5 Tc1 embryos exhibit outflow tract defects. Three-dimensional reconstructions of wild-type (A–C) and Tc1 (D–F, G– I) hearts. In all
samples analysed, the pulmonary artery (PA, white arrow, A, D, and G) arose from the right ventricle (RV). In the wild-type, the aorta arises from the
left ventricle (B and C), whereas in the Tc1 hearts, the position of the aortic valve (white circle, B, E, and H ) is shifted rightwards. Tc1 embryos can
exhibit DORV, both the pulmonary artery and the aorta arising from the right ventricle (E and F) and overriding aorta, the aortic valve (AV) sitting
centrally above a VSD, resulting in subaortic interventricular communication (H and I ). The models in C, F, and I have been eroded to the level of the
white box indicated in the respective insets. (LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle; PA, pulmonary artery; A, aorta; PV,
pulmonary valve; AoV, aortic valve).
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demonstrate that at E14.5, Tc1 embryos show many of the AV canal
defects associated with DS in humans.
3.4 DS-like heart defects in E18.5 Tc1
embryos
We also looked later in development at isolated hearts from E18.5
embryos, generated with C57BL/6J males. Again, a statistically signifi-
cant number of Tc1 samples exhibited heart defects at E18.5 (21%,
n ¼ 33; Table 1) compared with wild-type littermates. All affected
embryos had a VSD, either perimembranous (in the membranous
region of the ventricular septum) or muscular (in the inlet region of
the ventricular septum) (Figure 5B and D). One sample also showed a
DORV with subpulmonary interventricular communication and an
anterior aorta (Figure 5B; see Supplementary material online, Movie
S7) and another had an AVSD comprising a balanced common AV junc-
tion, guarded by a common five-leaflet valve and an unwedged left
outflow tract (Figure 5F and H; see Supplementary material online,
Movies S8 and S9). As with AVSD at E14.5, bridging leaflets of the
AV valve were anchored to the atrial but not the ventricular septum.
The frequency of malformations detected at E18.5 was noticeably
lower than that detected at E14.5 on the same genetic background
Figure 3 Abnormal arterial trunk arrangements in E14.5 Tc1embryos. Three-dimensional reconstructions of Tc1 hearts, showing abnormal arterial trunk
arrangements associated with DORV. Models are eroded in the short axis through the atria at the level of the aortic valve (A, C, E, and G) and the relative
position of the aortic and pulmonary trunks is shown in diagram (pale and dark grey, respectively). For each heart, a long-axis view of the interventricular
septum from the right ventricle (B,D, F, andH ) reveals the location of the septal defect (white circle), shown in detail in the adjacent panel (B*,D*, F*, andH*;
white arrowhead). Abnormalities range from failure of outflow tract septation, resulting in aortic-pulmonary continuity, with a doubly committed VSD(A and
B); subaortic ventricular communication with bilateral infundibulums and either side-by-side (C and D) or normal arrangement of arterial trunks (E and F);
subpulmonary VSD with side-by-side arterial trunks, equivalent to the Taussig–Bing anomaly in humans (G and H ). (Ao, aortic trunk; Pt, pulmonary trunk).
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(22 vs. 55%; Table 1). This difference is attributable at least in part to the
reduced incidence of detectable VSD in the older hearts, suggesting
that some of the septal defects detected at E14.5 are subsequently
closed during later development. (In humans, small, asymptomatic
VSDs have been detected by echocardiography in 5% of neonates,
with the overwhelming majority of these closing spontaneously
within 10 months.16) It may also be the result of reduced viability for
embryos with more severely malformed hearts.
In human DS, phenotype apparently varies with the percentage
of trisomic cells.17 In the Tc1 mouse, tissue retention of Hsa21 is
also mosaic, with 20–50% of cells in the hearts of adult Tc1 mice
retaining the Hsa21 transchromosome.7 Whether their distribution
is clonal, dispersed, or localized preferentially to individual cardiac
tissues is unknown since their identification by FISH has only
proved possible with dispersed cells rather than tissue sections.
Using expression of the Hsa21 gene SH3BGR18 as an alternative
marker of Hsa21-retaining cells in the myocardium, we found no
obvious association between distribution of Hsa21-expressing cells
at either E14.5 or E18.5 and the presence of morphological abnorm-
alities (see Supplementary material online, Figure S1).
Figure 4 E14.5 Tc1 embryos exhibit AV canal defects. Three-dimensional reconstructions of wild-type (A, G, and J ) and Tc1 (B, C, H, I, K, and L)
hearts eroded in the short or long axis (as indicated). (D–F) The corresponding sections (haematoxylin and eosin stain) from (A–C). In wild-type
hearts, the two AV junctions are separated by the AV septum (black asterix, A) and the left outflow tract (black arrow, A) sits in a ‘wedged’ position
between the mitral valve and AV septum. The tricuspid and mitral valves (D: black arrowheads and arrows, respectively) are therefore separate. In Tc1
hearts with AVSD (B, C, E, and F), a common AV junction can be guarded by a single valve (B) containing bridging leaflets (black arrows, E), or the
bridging leaflets can be joined along the crest of the ventricular septum (black arrow, F), giving two valvar orifices within the common AV junction (C).
In both cases, the ‘unwedged’ position of the left outflow tract is evident (black arrows, B and C). The AV bridging leaflets in Tc1 samples with AVSD
are anchored to the atrial septum (white arrow, H ) but not the ventricular septum (white arrowhead, H ). Other Tc1 samples show fat enlarged valves
within the AV junctions (compare valve leaflets in white boxes, G and I; leaflet thickness marked) or a cleft (or failure of fusion) in the anterior leaflet of
the mitral valve (white arrows, K and L) either with (white arrowhead, L) or without (K ) a VSD. (PV, pulmonary valve; AoV, aortic valve; R, right; L, left.
Scale bars in D, E, and F represent 500 mm.)
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3.5 Ts1Rhr mice do not exhibit cardiac
malformations
Since Tc1 embryos show a range of cardiac malformations to those
associated with DS, they provide a reference against which to
compare the effect of more partial trisomies of Hsa21 genes or
their murine counterparts. As a first step, we used HREM to assess
the morphology of hearts isolated from Ts1Rhr embryos.12 Strikingly,
in contrast to the Tc1 line, trisomy of only the 33 gene-containing
region equivalent to the DSCR in the Ts1Rhr line results in no statisti-
cally significant increase in cardiac malformations compared with wild-
type littermates (Table 1). This region is not therefore sufficient to
cause the DS heart phenotype in mice.
4. Discussion
The nature of the cardiac abnormalities associated with DS suggests
that trisomy affects cardiogenesis early, during chamber morphogen-
esis. Some of the existing mouse models for DS based on partial tri-
somies of Mmu16 do show cardiac abnormalities,9,10,19 but none
show the hallmark DS malformation of AVSD. This is a critical test
for a mouse model of DS, since the risk for this anomaly is increased
1000-fold among DS births and DS-associated AVSD accounts for
70% of all AVSD cases.20 AVSD abnormalities have been identified
in embryos of Ts16,21 a complete Mmu16 trisomy, but careful analysis
of AV junction morphology has revealed important differences with
the malformations seen in DS. Most DS AVSD comprises both a
common junction and common valve, which is balanced in its connec-
tion to both ventricular chambers.22 This arrangement has not been
detected in any Ts16 embryos. Instead, most show connection of
the common AV junction exclusively to the left ventricle, or with
only minimal connection to the right ventricle. Additionally, although
in DS, the aorta is generally connected exclusively to the left ventricle,
none of the Ts16 hearts showed this arrangement.23,24 Together,
these findings suggest that unlike DS, malalignment of the chambers
plays an important role in the in Ts16 cardiac malformations.
Here, we show that in contrast to the various Mmu16 trisomy
models, the Tc1 mouse replicates many of the specific features of
AVSD found in DS. All the Tc1 AVSDs were balanced between the
two ventricles, and in all but one case, the aorta was attached exclu-
sively to the left ventricle. Half of the cases showed a single common
AV orifice guarded by a five-leaflet valve typical of DS and several
showed a cleft mitral valve.25 These results suggest that genetic inter-
actions arising from genes outside of the region of synteny between
Hsa21 and Mmu16 are decisive for DS-like AVSD phenotypes in
mouse models.
4.1 Septal defects in Tc1 embryos
Similarities between the Tc1 model and DS extend to ventricular
septal defects, which in both is the most common heart abnormality.2
Moreover, the location of the septal lesions (membranous or muscu-
lar inlet portions with none in the outlet or trabeculated regions)
matches well those reported in DS.26 We have also detected
several outflow tract defects in Tc1 mice, most commonly over-riding
aorta, and DORV. DS infants have an elevated risk of both defects
(risk ratios of 200 and 21, respectively),6,20 although their absolute
frequency (3.46 and 1.7 per 1000, respectively) appears much lower
than in the Tc1 mouse. One notable disparity between Tc1 malfor-
mations and those found in DS is the absence of defects affecting
fusion of the atrial septum at the AV junction (the ‘ostium primum
septal defect’). Although such atrial septal defects are of obvious clini-
cal significance, from a developmental perspective, they remain sec-
ondary to the principal malformation, which is the failure to form
Figure 5 E18.5 Tc1 embryos exhibit AVSD, ventricular septal, and
outflow tract defects. Three-dimensional reconstructions of wild-
type (A, C, E, and G) and Tc1 (B, D, F, and H ) hearts eroded to
the levels indicated in the insets. (B) A Tc1 membranous VSD
(white arrowhead; four-chamber view) resulting in subpulmonary
interventricular communication, both arterial roots arising
side-by-side from the right ventricle (the Taussig–Bing malfor-
mation). (C–H) Short-axis view from apex. (D) A Tc1 muscular
inlet VSD (black circle, D). The left AV valve in the Tc1 heart is tri-
foliate in comparison to the normal mitral valve (compare E and F,
white arrows). This apparent cleft in the aortic leaflet can be
traced in continuity with the two bridging leaflets (white arrowheads,
H ) guarding a common AV junction (see also Supplementary
material online, Movie S9) (AoV, aortic valve; LA, left atrium; LV,
left ventricle; RA, right atrium; RV, right ventricle; A, aorta; PV, pul-
monary valve; R, right; L, left; VS, ventricular septum).
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separate left and right AV junctions.8 In DS, the resulting bridging leaf-
lets of the AVSD can be attached either to the atrial septum, resulting
in ventricular shunting (as we have found in Tc1 hearts); more com-
monly, they are attached to the crest of the muscular ventricular
septum, shunting confined to the atrial level (the ostium defect).
We have not yet encountered the latter type of AVSD in the Tc1
model. This may reflect important species differences in the relative
contributions of the many tissues forming the AV junction formation.
Other factors may be the incomplete nature of the Hsa21 transchro-
mosome, mosaicism in transchromosome distribution, or the impact
of mouse strain background.
The influence of genetic background on heart abnormalities in
mutant mice is well established and our detection of strain-dependent
variation in the prevalence of Tc1 cardiac malformations is reminis-
cent of the finding that the prevalence and subtypes of CHD associ-
ated with DS vary in different human populations.27 Furthermore, two
genetic loci for familial AVSD have been identified outside of
Hsa21,28– 30 leading to the suggestion that a combination of poly-
morphisms/mutations on non-Hsa21 genes, environmental influences,
and trisomy of Hsa21 are all involved in the susceptibility for DS indi-
viduals to develop cardiac malformations.31 One noteworthy obser-
vation from our study was the detection of cardiac defects (all but
one, VSD) in 10% of the wild-type littermates of Tc1 embryos at
E14.5. Overall heart size and the morphology of other organs indicate
that this is unlikely to be due to inaccurate embryo staging, nor does it
easily account for the detection of muscular VSDs in the trabecular
portion of the interventricular septum in several wild-type hearts.
Our finding may simply reflect the very large number of embryos
examined in the study (71 wild-types at E14.5) and the sensitivity
afforded by the HREM 3D modelling technique. In humans, small,
asymptomatic VSDs have been detected by echocardiography in 5%
of neonates, with the overwhelming majority of these closing spon-
taneously within 10 months.16 It will be of interest in future to estab-
lish the extent to which genetic background contributes to this basal
level of cardiac malformations in the mouse and the proportion that is
subsequently repaired during development. We cannot rule out the
possibility that subtle developmental delay of the Tc1 embryos
accounts for a proportion of the phenotypes we detect (e.g. some
VSDs) but we have no evidence for such delay either in embryo
size, heart size, or development of any other organ. Nor, importantly,
is it possible for such a delay to provide a credible explanation for the
persistence of a balanced, common AV junction in some Tc1
embryos.
One potential difficulty with the Tc1 line as a model of DS is the
mosaic and variable distribution of cells containing the Hsa21 trans-
chromosome.7 In human mosaic DS cases, variation in phenotypes
has been associated with the percentage of trisomic cells17 but appro-
priate tools for establishing whether a comparable link exists in the
Tc1 mouse are not yet available. Species-specific in situ hybridization
for SH3BGR expression indicates no obvious correlation between
mosaicism and phenotype, but because of the tissue-specific pattern
of its expression, using this marker can only reveal the extent
of trisomy in the myocardium of the heart. Other tissues such as
the endocardial cushions, the mesenchymal cap of primary atrial
septum, and dorsal mesenchyme protrusion (DMP or vestibular
spine) are important for septation and AV junction formation
(see below) and methods to establish Hsa21 transchromosome
distribution in these tissues will therefore be important in future
studies.
4.2 Identification of causative genes
Since endocardial tissue is a major contributor to the AV junction, dis-
ruption of the normal genetic programme of the endocardial cushions
has long been considered the most likely explanation for DS heart
defects. One hypothesis is that trisomy of the two regulators of
nuclear factor of activated T-cells (NFAT) signalling, Dyrk1a and
Rcan1 (Dscr1), disrupts regulation of NFAT activity, leading to a
number of DS phenotypes including those affecting the heart.32,33
However, RCAN1 is not present in the Hsa1 transchromosome of
Tc1 mice, nor is it identified in the most recent phenotype mapping
of DS using human partial Hsa21 trisomies,5 indicating that trisomy
of this gene cannot be essential for the DS cardiac phenotype. The
same mapping study also suggested that DYRK1A was unlikely to be
necessary for DS cardiac phenotypes, a conclusion matched by our
findings comparing the Tc1 and Ts1Rhr mouse models.
Another proposed candidate causative gene is DSCAM, which,
unlike RCAN1 or DYRK1A, lies within the latest suggested critical
region for DS–CHD5 and also within the DSCR syntenic region
of Mmu16 in the Ts1Rhr mouse.12 Ts1Rhr has been used to identify
a candidate gene for a DS phenotype,34 but the 33 gene-containing
trisomic region does not yield any of the DS-like craniofacial
defects12 or brain phenotypes exhibited by other partial trisomy
16 mouse models.35 Our study now demonstrates that this region
is also insufficient for any of the DS-like cardiac phenotypes.
Trisomy of DSCAM is therefore unlikely to be sufficient to yield DS
cardiac abnormalities.
Recent studies suggest that rather than resulting from a defect in
endocardial cushion tissue, AVSD results from abnormalities in the
musculature. In particular, the dorsal mesenchymal protrusion
(DMP or vestibular spine) has been identified as a critical component
of the AV junction.36– 40 Derived from ‘second heart field’ cells of the
dorsal body wall rather than by epithelial to mesenchymal transition
of cushion tissue, the DMP forms a wedge projecting into the atrial
cavity and gives rise to the myocardial base of the primary atrial
septum. Disruption of DMP development results in atrial and AV
defects,41 as does the loss of Wnt2 signalling,20 which reduces pro-
liferation of cardiac mesoderm progenitors of the cardiac inflow
tract (including the DMP). These findings lend powerful support to
the view that defects in the DMP underlie AVSD abnormalities such
as those prevalent in DS.42,43
Whether the most fruitful way to identify genes responsible for
DS-associated CHD is by identification of likely candidates or
through the mapping of critical or susceptibility regions for particular
DS phenotypes,5 it is evident that progress will depend on robust
methods to correlate genotype and variably penetrant phenotypes
in the mouse. Increasing numbers of partial trisomy models can
now be combined with individual gene deletions to permit sophisti-
cated manipulation of gene dosage, encompassing Hsa21-syntenic
regions of Mmu10 and Mmu17, as well as Mmu16. Analysis of the
embryos produced by such studies will be a formidable challenge.
We have shown that systematic, high-resolution 3D modelling of
embryo heart morphology using HREM provides an effective way to
combine sensitive detection of DS-like cardiac abnormalities with
the systematic screening that such studies will require.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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